The bacterial ghost (BG) system represents a novel and progressive approach in the development of bacterial mediated cancer immunotherapy. The empty inner space of BGs can be filled with drugs, proteins, DNA, enzymes and other compounds. The induced lysis process does not harm the essential structural components of the bacteria, giving rise to immunologically active particles capable of stimulating the host immune system and delivering specific antigen (Ag) to professional antigenpresenting cells (APCs) or active substances to the target cells (1,2).
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Despite the large number of various anti-cancer drugs on the market, proper delivery systems are needed to decrease serious toxic and non-curative side effects. In order to enhance compliance, several delivery systems such as polymeric micro-and nanoparticles, liposomal systems and erythrocyte ghosts have been developed. Bacterial ghosts (BGs) represent novel advanced delivery and targeting vehicles suitable for delivery of hydrophobic or water-soluble drugs. BGs are empty bacterial envelopes of Gram-negative bacteria produced by controlled expression of cloned gene E, forming a lysis tunnel structure within the envelope of the living bacteria. BGs are devoid of cytoplasmic content and possess all bacterial bio-adhesive surface properties in their original state while not posing any infectious threat. BGs are ideally suited as an advanced drug delivery system for toxic substances in tumor therapy. The inner space of BGs can be loaded with either single components or combinations of peptides, drugs or DNA which provides an opportunity to design new types of (polyvalent) drug delivery vehicles. In particular, Doxorubicin-loaded bacterial ghosts have been used to target colon carcinoma cells. DOX, a cytotoxic drug commonly used in cancer therapy, was used as a model substance to demonstrate the delivery of moderate water-soluble drugs by BGs. The application of DOX with BGs increased the efficacy of treatment by two folds. The same effect was observed after incubation of leukemia cells and melanoma cells with DOX loaded BGs.
Production of bacterial ghosts
BGs are produced by expression of cloned gene E from bacteriophage ϕX174 resulting to cell lysis in Gram-negative bacteria, such as, Escherichia coli K12 strains, Klebsiella pneumoniae, Mannheimia (Pasteurella) haemolytica, Neisseria meningitidis, Salmonella typhimurium, Vibrio cholera, Helicobacter pylori, and others (3, 4) . Expression of gene E can be placed under transcriptional control of either the thermo sensitive EpL/pR-cI857 promoter, or under chemical inducible promoter repressor systems, like lacPO or the tol expression system. Gene E codes for 91 amino acids and exerts its lytic function by fusion of the inner and outer cell membranes, forming a specific transmembrane tunnel structure through which all the cytoplasmic content is expelled, thus leaving a bacterial envelope called a BG devoid of nucleic acids, ribosomes and other intracellular constituents. The inner membrane (IM) and outer membrane (OM) structures of BGs remain intact during the lysis process (5, 6) . Electron microscopy studies and enzymatic studies clearly showed a sealed periplasmic space at the border of the lysis tunnel. The efficiency of the E-mediated lysis process, and quantification of generated BGs and non lysed viable bacteria are determined by flow cytometry assays using a specific dye that is sensitive to the changes of discriminatory power of membrane potential and stains only cells that have lost membrane potential (BGs or dead bacteria).
Bacterial ghosts as advanced drug delivery systems
Many diseases including cancers require the systemic administration of highly aggressive drugs to already immunocompromised patients. Deleterious and often severe side effects result from a lack of cellular and tissue selectivity. Another major issue is the poor solubility of some drugs used in cancer treatment. Considering these limitations, the development of a safer and more efficient drug delivery system (DDS) is the priority for future advanced cancer treatments (7). Recently, bacterial ghosts made from the colonic commensal Mannheimia haemolytica were used for in vitro delivery of doxorubicin (DOX) to human colorectal adenocarcinoma (Caco-2) cells. Adherence studies showed that the M. haemolytica ghosts targeted the Caco-2 cells and released the loaded DOX within the cells. Cytotoxicity assays showed a two folds enhancement in cytotoxic and anti-proliferative activity in cells incubated with DOX-loaded ghosts as compared with cells for which DOX was directly added to the culture media (8) . This phenomenon might be caused by degradation of DOX-loaded BGs within the endolysosome of target cells allowing DOX to bypass the multi-drug resistance (MDR) efflux pumps and resulting in enhanced accumulation of DOX in the cytoplasm and then in the nuclear area of target cells.
Current work with bacterial ghosts lies in the investigation of the carrier capacity of the cytoplasmic lumen. This intracellular space of BGs can be filled either with water-soluble substances or emulsions such that the drug(s) of interest can be coupled to streptavidin anchored on the inside of the cytoplasmic membrane. Moreover, bacterial ghosts can be filled and sealed for the delivery of fluid, non -anchored substances. In a recent study, E. coli ghosts were filled with the reporter substance calcein and were sealed by fusion with membrane vesicles to maintain inner membrane integrity. Adherence and uptake studies showed that murine macrophages and human Caco-2 cells took up the bacterial ghosts, and calcein was released within the cells (1,7,9).
Bacterial ghosts as immunologically active particles
Because of the unique structure of the BG's envelope with preserved pathogen-associated molecular patterns (PAMPs), BGs can be used in biomedicine alone as an adjuvant or as a delivery vehicle for drugs or genes. The inner space of BG's empty envelope can be loaded with a combination of peptides, drugs or foreign DNA which gives us an opportunity to design new types of polyvalent vaccines (9) . BGs have excellent DNA loading capacity varying from 4000 to 6000 plasmid copies per BG depending on the concentrations of DNA solution used (10) (11) (12) (13) 
